Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EV/Net Sales

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EV/Net Sales History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EV/Net Sales(x) 3.667.217.334.945.03

What is the latest EV/Net Sales ratio of NATCO PHARMA ?

The latest EV/Net Sales ratio of NATCO PHARMA is 3.66 based on Mar2023 Consolidated results.
Year EV/Net Sales
Mar20233.66
Mar20227.21
Mar20217.33
Mar20204.94
Mar20195.03

How is EV/Net Sales of NATCO PHARMA Trending?

Years EV/Net Sales % Change
Mar2023 3.66
-49.24
Mar2022 7.21
-1.64
Mar2021 7.33
48.38
Mar2020 4.94
-1.79
Mar2019 5.03 -

Other Financial Ratios of NATCO PHARMA


Compare EV/Net Sales ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹18,277.2 Cr 2.1% 2.1% 65.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹356,673.0 Cr -2.9% 0% 59.6% Stock Analytics
CIPLA ₹119,930.0 Cr 5.8% 6.2% 60.9% Stock Analytics
DIVIS LABORATORIES ₹109,446.0 Cr 5% 8% 25.9% Stock Analytics
ZYDUS LIFESCIENCES ₹108,261.0 Cr -2.6% 15.3% 114.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,830.6 Cr 0.9% -1.5% 32.2% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

2.1%

2.1%

65.5%

SENSEX

2%

2.3%

22.2%


You may also like the below Video Courses